BPMC

Blueprint Medicines Corporation (BPMC)

About Blueprint Medicines Corporation (BPMC)

Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Details

Daily high

$89.88

Daily low

$88.10

Price at open

$89.08

52 Week High

$121.90

52 Week Low

$43.89

Market cap

5.6B

Dividend yield

0.00%

Volume

48,846

Avg. volume

714,259

P/E ratio

-25.73

Blueprint Medicines Corporation News